|
|
|
|
| LEADER |
01629nmm a2200349 u 4500 |
| 001 |
EB002187269 |
| 003 |
EBX01000000000000001324756 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
231108 ||| eng |
| 100 |
1 |
|
|a Malek, Thomas
|
| 245 |
0 |
0 |
|a IL-2 in the immunotherapy of autoimmunity and cancer
|h Elektronische Ressource
|c Thomas Malek
|
| 260 |
|
|
|a London
|b Henry Stewart Talks
|c 2023, 2023
|
| 300 |
|
|
|a 1 streaming video file (40 min.)
|b color, sound
|
| 505 |
0 |
|
|a Contents: IL-2Rs -- IL-2 and regulatory T cells -- Therapy for autoimmune diseases -- Low-dose IL-2 -- Clinical testing -- IL-2 for autoimmunity and cancer -- Mouse IL-2/CD25 fusion protein -- Key properties of IL-2/CD25 -- IL-2 as a cancer immunotherapy -- IL-2-dependent anti-tumor immunity -- High-dose IL-2/CD25 -- Clinical implications
|
| 653 |
|
|
|a Interleukin-2 / therapeutic use
|
| 653 |
|
|
|a Autoimmune Diseases / drug therapy
|
| 653 |
|
|
|a Neoplasms / immunology
|
| 653 |
|
|
|a Autoimmune diseases / Immunotherapy
|
| 653 |
|
|
|a Interleukin-2
|
| 653 |
|
|
|a Immunotherapy / methods
|
| 653 |
|
|
|a Cancer / Immunotherapy
|
| 653 |
|
|
|a Neoplasms / drug therapy
|
| 653 |
|
|
|a T-Lymphocytes, Regulatory
|
| 653 |
|
|
|a Receptors, Interleukin-2
|
| 653 |
|
|
|a Mice
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b HST
|a Henry Stewart Talks
|
| 490 |
0 |
|
|a The biomedical & life sciences collection
|
| 500 |
|
|
|a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web
|
| 856 |
4 |
0 |
|u https://hstalks.com/bs/5446
|x Verlag
|z Streaming video file
|
| 082 |
0 |
|
|a 570
|